Overview

Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures

Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy of pregabalin and gabapentin, as adjunctive therapy in subjects with partial seizures.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Gabapentin
gamma-Aminobutyric Acid
Pregabalin